Tumor infiltrating lymphocytes: current pathways to a standard biomarker in breast cancer

William T Tran^{1

2}, Fang-I Lu³, Roberto Salgado^{4

5}

Affiliations

¹ Department of Radiation Oncology, Sunnybrook Health Sciences Centre, Toronto, Canada.
² Department of Radiation Oncology, University of Toronto, Toronto, Canada.
³ Pathobiology and Laboratory Medicine, University of Toronto, Toronto, Canada.
⁴ Department of Pathology, GZA-ZNA Hospitals, Antwerp, Belgium.
⁵ Division of Research, Peter Mac Callum Cancer Centre, Melbourne, Australia.

Editorial

William T Tran et al. Expert Rev Anticancer Ther. 2021 Dec.

. 2021 Dec;21(12):1299-1301.

doi: 10.1080/14737140.2021.1953987. Epub 2021 Jul 24.

William T Tran^{1

2}, Fang-I Lu³, Roberto Salgado^{4

5}

¹ Department of Radiation Oncology, Sunnybrook Health Sciences Centre, Toronto, Canada.
² Department of Radiation Oncology, University of Toronto, Toronto, Canada.
³ Pathobiology and Laboratory Medicine, University of Toronto, Toronto, Canada.
⁴ Department of Pathology, GZA-ZNA Hospitals, Antwerp, Belgium.
⁵ Division of Research, Peter Mac Callum Cancer Centre, Melbourne, Australia.

No abstract available

Keywords: Tumor-infiltrating lymphocytes; biomarkers; breast cancer; tumor immune microenvironment.

Publication types